| Hans-Günter Meyer-Thompson | Fachartikel
A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment.
A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment.
Fenton F, Stokes S, Eagleton M.
Ir J Med Sci. 2022 Jun;191(3):1053-1058. doi: 10.1007/s11845-021-02660-w. Epub 2021 Jul 9. Erratum in: Ir J Med Sci. 2021 Aug 26;: PMID: 34241774; PMCID: PMC8267507.